109. 非典型溶血性尿毒症症候群 Atypical hemolytic uremic syndrome Clinical trials / Disease details

臨床試験数 : 114 / 薬物数 : 36 - (DrugBank : 7) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 11

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005186-13-SI (EUCTR)	05/11/2021	14/09/2021	Efficacy and safety of iptacopan (LNP023) in adult patients with atypical hemolytic uremic syndrome ...	A multicenter, single-arm, open label trial to evaluate efficacy and safety of oral, twice daily LNP ...	atypical hemolytic uremic syndrome MedDRA version: 20.1;Level: LLT;Classification code 10079841;Term ...	Product Name: iptacopan Product Code: LNP023 INN or Proposed INN: iptacopan Other descriptive name: LN ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 3	United States;Czechia;Taiwan;Slovenia;Greece;Austria;Russian Federation;United Kingdom;India;Hungary ...
2	EUCTR2020-005186-13-AT (EUCTR)	26/08/2021	27/05/2021	Efficacy and safety of iptacopan (LNP023) in adult patients with atypical hemolytic uremic syndrome ...	A multicenter, single-arm, open label trial to evaluate efficacy and safety of oral, twice daily LNP ...	atypical hemolytic uremic syndrome MedDRA version: 20.1;Level: LLT;Classification code 10079841;Term ...	Product Name: iptacopan Product Code: LNP023 INN or Proposed INN: iptacopan Other descriptive name: LN ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 3	United States;Czechia;Taiwan;Slovenia;Greece;Austria;Russian Federation;United Kingdom;India;Hungary ...

First Previous1Next Last